Loading...
Novel Experimental Drugs for Treatment of Multiple Myeloma
Multiple myeloma (MM) is the second most frequent hematological malignancy characterized by bone marrow aberrant plasma cells proliferation leading to a genetic complex and heterogeneous disease, with a median survival ranging from two to more than 10 years. By using new drugs such as proteasome inh...
Na minha lista:
| Udgivet i: | J Exp Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955760/ https://ncbi.nlm.nih.gov/pubmed/33727866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S265288 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|